Duke Geem, David Hercules, Ranjit S Pelia, Suresh Venkateswaran, Anne Griffiths, Joshua D Noe, Jennifer L Dotson, Scott Snapper, Shervin Rabizadeh, Joel R Rosh, Robert N Baldassano, James F Markowitz, Thomas D Walters, Ashwin Ananthakrishnan, Garima Sharma, Lee A Denson, Jeffrey S Hyams, Subra Kugathasan
BACKGROUND & AIMS: The evolution of complicated pediatric Crohn's disease (CD) in the era of anti-tumor necrosis factor (aTNF) therapy continues to be described. Because CD progresses from inflammatory to stricturing (B2) and penetrating (B3) disease behaviors in a subset of patients, we aimed to understand the risk of developing complicated disease behavior or undergoing surgery in relation to aTNF timing and body mass index z-score (BMIz) normalization. METHODS: Multicenter, 5-year longitudinal data from 1075 newly diagnosed CD patients were analyzed...
October 5, 2023: Clinical Gastroenterology and Hepatology